MARKET

RVNC

RVNC

Revance Therapeu
NASDAQ
31.06
+0.65
+2.14%
After Hours: 31.06 0 0.00% 16:03 06/02 EDT
OPEN
30.43
PREV CLOSE
30.41
HIGH
31.37
LOW
30.26
VOLUME
917.48K
TURNOVER
0
52 WEEK HIGH
37.98
52 WEEK LOW
11.27
MARKET CAP
2.61B
P/E (TTM)
-6.7426
1D
5D
1M
3M
1Y
5Y
Revance Therapeu: Report of proposed sale of securities
Press release · 1d ago
Revance Therapeu: Statement of changes in beneficial ownership of securities
Press release · 05/16 20:30
HC Wainwright & Co. Maintains Revance Therapeutics (RVNC) Buy Recommendation
NASDAQ · 05/10 20:51
Needham Maintains Revance Therapeutics (RVNC) Buy Recommendation
NASDAQ · 05/10 20:51
Needham Maintains Buy on Revance Therapeutics, Raises Price Target to $44
Benzinga · 05/10 17:24
Revance Therapeutics (RVNC) Receives a Buy from Piper Sandler
TipRanks · 05/10 11:25
HC Wainwright & Co. Maintains Buy on Revance Therapeutics, Raises Price Target to $48
Benzinga · 05/10 10:47
--HC Wainwright Adjusts Price Target on Revance Therapeutics to $48 From $42, Maintains Buy Rating
--HC Wainwright Adjusts Price Target on Revance Therapeutics to $48 From $42, Maintains Buy Rating
MT Newswires · 05/10 10:16
More
About RVNC
Revance Therapeutics, Inc. is a biotechnology company. The Company is focused on advanced aesthetic and therapeutic offerings. The Company’s aesthetics portfolio of expertly created products and services, including DAXXIFY (DaxibotulinumtoxinA-lanm) for injection, the RHA Collection of dermal fillers, and OPUL, the first-of-its-kind relational commerce platform for aesthetic practices. The Company’s therapeutics pipeline is focused on muscle movement disorders, including evaluating DAXXIFY in two debilitating conditions, cervical dystonia and upper limb spasticity. The DaxibotulinumtoxinA for Injection combines a proprietary stabilizing peptide excipient along with the other excipients. DAXXIFY a commercially approved product, is an acetylcholine release inhibitor and neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.

Webull offers kinds of Revance Therapeutics Inc stock information, including NASDAQ:RVNC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVNC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RVNC stock methods without spending real money on the virtual paper trading platform.